2
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Polycystic Ovary Syndrome
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Leukemia, Myeloid, Acute
3
Diabetes Mellitus, Type 2
3
Myelodysplastic Syndromes
2
Lymphoma, Non-Hodgkin
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Glioblastoma
2
Thyroid Nodule
1
Renal Insufficiency
1
Pancreatic Neoplasms
1
Neoplasms, Adipose Tissue
1
Multiple Endocrine Neoplasia Type 1
1
Lymphoma, Follicular
1
Leukemia, Myelomonocytic, Chronic
1
Kidney Failure, Chronic
1
Insulin Resistance
1
Infertility
1
Glioma
1
Colorectal Neoplasms
1
Breast Neoplasms
1
Brain Neoplasms
1
Body Weight
1
Anemia, Refractory, with Excess of Blasts
1
Interventions
selinexor
1
pazopanib
1
Sitagliptin Phosphate
1
Proton Therapy
1
Ifosfamide
1
Doxorubicin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasms, Adipose Tissue
×
Sitagliptin Phosphate
×
Clear all
NCT02294084
2018-07-16
Sita01
Leiden University Medical Center
Phase 4
Completed
30 enrolled